Policybazaar After the Cap: Is the Marketplace Still a Moat?

The day after IRDAI published its distribution reforms, PB Fintech's management held an analyst call. On general insurance, they said, the proposals would leave them with "between one-third to 40% of what we have today. That's a very serious impact on revenue." Management says it has spent 18 years building the marketplace. The question now is whether a marketplace is still a moat when the regulator sets its price.

The business going into the change

PB Fintech's Q1 FY27 results, filed in August, showed a business at full speed ([Q]):

• total insurance premium of ₹8,372 crore, up 41%;
• operating revenue of ₹1,888 crore, up 40%, of which core insurance revenue was ₹1,067 crore;
• profit after tax of ₹163 crore, up 92%, which is 1.9% of premium;
• core insurance renewal revenue at an annualised ₹999 crore, up 48%, which the company calls "a key driver of long-term profit growth";
• its agent platform PB Partners (point-of-sale persons, or POSPs) with ₹1,637 crore of premium and ₹561 crore of revenue.

The model depends heavily on health insurance and renewals. New health premium grew 59% in the quarter ([Q]). Those are exactly the lines IRDAI proposes to cap hardest.

What IRDAI proposes, as it applies to PB

Policybazaar is a broker. Under the proposals, brokers become "Insurance Distribution Entities" (IDEs), and IDEs get lower commission caps than insurers' own agents ([C]):

Several other proposals reach the model directly ([C]):

• Lead generation. Product and price information must be available without asking for personal details, and "Access to information should not be used as a lead generation opportunity".
• Money flows. Premiums must move straight from the customer's account to the insurer's, and IDEs must "not handle customers' money".
• POSP payouts. Commissions to POSPs engaged by an IDE "should come out of the commission of their principal distribution entity".
• Insurer-owned platforms. Not-for-profit digital platforms owned by insurers, such as Bima Sugam, are to have "preferred distribution status". For motor, they may charge a fee of no more than 5% of premium.

Management's own arithmetic

On the 24 September call, management walked through the impact ([T]):

• Life insurance value is "in the same neighborhood as it is today, it is not the same".
• General insurance falls to one-third to 40% of today. Core revenue is "roughly half" general and half life. So if general insurance revenue is cut by 60%, as management used in its example, total core revenue falls about 30%.
• Volume should partly offset it. Because PB works with insurers on a combined-ratio basis, lower commissions could mean lower prices. Management cited a "price elasticity of at least 1" and said "at least 15-20% we should get back in terms of growth".
• Costs will be cut. The contact centre is "almost 20% of our revenue". Marketing at the margin stops paying: "we were spending ₹100 to make ₹100, at the margin", and under the caps that ₹100 would bring in about ₹30. The company "hired about 6,000 people" in the first half, and hiring will slow, though management promised "no mass layoffs".
• PB Partners faces a harder problem: "if you read the regulation as it is, the business is challenged".
• Timing. "This is not going to have any short-term impact on FY27", but "FY28 will be a year of challenges and discovery".

In its 27 September letter to the exchanges, the company said the proposed limits "may not fully reflect the current operational and servicing cost structures of the online insurance distribution" and that it will make representations to IRDAI ([K]).

The margin: set by someone else

PB's own figure puts its margin in context: profit is "still under 2% of total premiums" ([T]). Its revenue per policy, though, is set by commission. Under the proposals that commission would be capped by the regulator rather than negotiated, and the caps sit below today's levels in exactly the lines where PB is strongest.

Management wants to turn the cut into a price advantage: "if Policybazaar is getting paid less than, let's say, channel ABCD, then we must be allowed to offer that delta as a price advantage" ([T]). That is the second mode of MoatSCORE's price discretion test (D4): holding prices down by choice and still earning superior returns. Whether PB can pass it depends on insurers passing lower costs on to customers. The paper hopes for that, but does not require it.

The moat: what survives a capped price

Focus moat: D1, network effects. Policybazaar's case for a moat has always been the marketplace. Customers come because the insurers are there, and insurers come because the customers are. MoatSCORE's core test is that a moat "is proven when competitors try and fail". Management made exactly that argument on the call: "If this was such a lucrative industry, we should have at least 10 more competitors. I can't even think of one standing with us today" ([T]).

The proposals test that moat from three sides:

1. Price discretion (D4) goes away. A regulator-set commission removes the ability to charge for the marketplace's value. Whatever network effect exists must now show up as volume, not price.
2. A subsidised rival arrives. Bima Sugam and similar platforms would be not-for-profit, owned by insurers, with preferred status ([C]). That is counter-positioning (D7) aimed at PB, backed by the regulator.
3. Some features favour PB. IRDAI's own data shows 71% of life policies bought online still running at the 61st month, against 48% overall ([C]). IDEs would also be allowed to sell non-insurance financial products ([C]). Before Paisabazaar existed, "25% of Policybazaar's revenue used to be credit cards and personal loans" ([T]).

Management's longer-term answer is to own more of the risk. It wants IRDAI to allow managing general agents (MGAs), and it said: "there would be a higher probability of us having some manufacturing capability of our own" ([T]). That would turn a distribution moat into an underwriting business, with different capital needs and different risks.

MoatSCORE snapshot

The score is as published on 28 September 2026 ([MS]) and has not been re-scored for these proposals.

The bear case, taken seriously

• The core cut is large. On management's own illustration, total core revenue falls about 30% before any recovery in volume ([T]).
• Renewals are the most exposed. The renewal book, now ₹999 crore annualised, is what makes the model profitable over time ([Q]). A 5% cap on health renewals for IDEs goes straight at it ([C]).
• POSP economics break. POSPs would be paid out of the IDE's own lower cap, while insurers' agents get higher caps ([C]). Management called the business "challenged" ([T]).
• Distributors were not consulted. "I just wanted to clarify there has been no consultation with distributors" ([T]). That makes the final shape of the rules harder to predict.
• Becoming an insurer is a different business. Moving into underwriting would need capital and regulatory approval, and would change what investors own.

The case that it holds

• It is a draft. Comments close on 25 October 2026 ([C]). Management expects "some room for a little bit of walk back" ([T]).
• FY27 is unaffected. On management's account, the change does not begin until the new financial year ([T]).
• Cost is flexible. A company that has been spending ₹100 to earn ₹100 at the margin can stop doing so.
• Quality has data behind it. Online persistency of 71% is IRDAI's own figure ([C]).

What to watch

1. The final caps after 25 October, especially health renewals and the IDE-versus-agent gap.
2. Whether the caps apply to existing policies' renewals.
3. PB's Q2 FY27 results and commentary on hiring, marketing spend and renewal revenue.
4. Any application for an MGA, insurance or reinsurance licence.
5. Bima Sugam's launch and its fee structure.

Sources

• [T] PB Fintech, transcript of analyst & investor call held on 24 Sep 2026 (NSE)
• [K] PB Fintech, clarification on price movement, 27 Sep 2026 (NSE)
• [Q] PB Fintech, Q1 FY27 results, 5 Aug 2026 (NSE)
• [C] IRDAI, "Recalibrating Economics of Insurance Distribution", Public Consultation Paper, 23 Sep 2026
• [MS] Moat & Margin, Moat Screener and How MoatSCORE works

Educational research, not investment advice. Every figure above is drawn from PB Fintech's own filings and IRDAI's public consultation paper, read from the primary documents on 28 September 2026. The MoatSCORE is as published on the Moat Screener on that date. No buy/sell recommendations, no price targets. Moat & Margin is not a SEBI-registered Research Analyst or Investment Adviser.